AzTrials
AzTrials

Inactivity, PhysicalNCT07146867

Effects of One HIIT Session on Adiponectin Isoforms

A study testing High intensity interval training (exercise) in people with Inactivity, Physical, run by Universidad San Sebastián at 1 site in Chile.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational quasi-experimental study is to evaluate whether a single session of high-intensity interval training (HIIT) can acutely modulate metabolic markers, particularly adiponectin isoforms, in insufficiently active young adults (men and women, 18-29 years, free of cardiometabolic disease). Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Inactivity, Physical
What is being tested?
High intensity interval training (exercise)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteChile
Study dates
1 Mar 2023to 15 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age between 18 and 29 years
  • Engage in less than 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week)
  • Having no positive responses on the PAR-Q \& YOU questionnaire

Who cannot join

  • Diagnosis of cardiometabolic disease
  • Use of anti-inflammatory treatment during the week prior to participation

Trial locations and contacts

1 site in 1 country.

Chile1 site
  • Universidad San Sebastián

    Valdivia, Los Ríos Region, 5090000

Other trials in Chile

About this study

Official title: Metabolic Responses to a Single Session of High-intensity Interval Training in Insufficiently Active Young Adults. Effects on Adiponectin Isoforms

The goal of this observational quasi-experimental study is to evaluate whether a single session of high-intensity interval training (HIIT) can acutely modulate metabolic markers, particularly adiponectin isoforms, in insufficiently active young adults (men and women, 18-29 years, free of cardiometabolic disease).

The main questions it aims to answer are:

Read more

Does a single HIIT session increase circulating medium- and high-molecular-weight adiponectin?

Does HIIT acutely alter lipid and glucose metabolism markers such as non-HDL cholesterol, insulin, and lactate?

Participants completed the following tasks:

Underwent baseline assessments (anthropometry, body composition, and resting cardiovascular parameters).

Performed one HIIT session consisting of six 3-minute intervals at 80% heart rate reserve, each followed by 3 minutes of active recovery.

Provided blood samples before and immediately after exercise to analyze adiponectin isoforms (LMW, MMW, HMW) via Western blot and to measure glucose, insulin, lipid profile, liver enzymes, and lactate.

Summary of findings:

A single HIIT session significantly increased medium-molecular-weight adiponectin (~19%), decreased the HMW/MMW ratio, and elevated lactate and non-HDL cholesterol. No significant changes were observed in LMW or HMW adiponectin. These results suggest that MMW adiponectin is an early, sensitive marker of acute exercise response in sedentary young adults, though further research is needed to confirm long-term implications

Being tested
High intensity interval training (exercise)
Keywords
adiponectin, high intensity interval training
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High intensity interval training (exercise)Behavioural

    One 30 minute session of high intensity interval training

Study groups in NCT07146867
Study groupRoleWhat they receive
High intensity interval trainingExperimentalOne session of high intensity interval training
Receives: Behavioral: High intensity interval training (exercise)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adiponectin isoforms

    Measured: Before and immediately after the exercise session

  2. Adiponectin isoforms

    Measured: Before and immediately after the exercise session (30 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2025
  2. Study start1 Mar 2023
  3. Primary completion1 Dec 2024
  4. Study completion15 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07146867
Sponsor's protocol ID
AcuteHIIT
Status last verified
Apr 2026
First submitted
21 Aug 2025
Last updated
5 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Alvarado-Carrasco D, Gonzalez-Maraboli A, Reyes-Montalva M, Videla-Aguilar J, Bentes A, Penailillo L, Sandoval V, Martinez-Huenchullan S. Acute effects of high-intensity interval training on adiponectin isoforms in inactive young adults: a quasi-experimental study. BMC Sports Sci Med Rehabil. 2025 Dec 30;17(1):387. doi: 10.1186/s13102-025-01433-7.

    PubMed 41469733

Questions about this trial

What is this clinical trial studying?

A study testing High intensity interval training (exercise) in people with Inactivity, Physical, run by Universidad San Sebastián at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adiponectin isoforms (time frame: Before and immediately after the exercise session). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07146867, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in